Hybrid renal tumor and its atypical spectrum: Case report and review of the literature
DOI:
https://doi.org/10.48193/revistamexicanadeurologa.v82i6.965Keywords:
Renal mass, renal oncocytoma, chromophobe renal cell carcinoma, hybrid oncocytic/chromophobe tumorAbstract
Clinical case: Hybrid renal tumor is defined as that neoplasm whose components are given by the presence of oncocytes (oncocytoma) and chromophobe cells whose preoperative diagnosis is challenging due to its great similarity with typical oncocytoma. Its modalities of presentation include hereditary and sporadic, the first being the most frequent, associated with the involvement of other organs such as the skin and the lungs.
Clinical implications: We present the case of a 9-year-old female patient, a primary school student, who was incidentally found to have a mass on the left flank, not painful on palpation, fixed, of approximately 8 cm, for which Ultrasound, abdominal tomography, and renal angiotomography were performed, confirming the presence of a large, well-defined left renal mass, heterogeneous by area of central necrosis, with no evidence of infiltration to adjacent structures or vascular invasion whose histopathological report revealed hybrid renal oncocytoma, for which is taken to laparoscopic total nephrectomy, presenting adequate evolution in its follow-up.
Relevance: Familiarizing ourselves with the spectrum of renal masses in schoolchildren is of vital importance since they are benign neoplasms, which prevents the use of necessary measures.
Conclusion: Rapid identification allows timely surgical lesions with less morbidity in patients, so it is important that different specialists know their imaging findings.
References
Zhao S, Shi J, Yang R, Zhang X, Zhao W, Sun Z. Ultrasonography findings for the diagnosis of renal oncocytoma. J Med Ultrasonics. 2022;49(2):211–6. doi: https://doi.org/10.1007/s10396-021-01179-y
Marko J, Craig R, Nguyen A, Udager AM, Wolfman DJ. Chromophobe Renal Cell Carcinoma with Radiologic-Pathologic Correlation. RadioGraphics. 2021;41(5):1408–19. doi: https://doi.org/10.1148/rg.2021200206
Abdessater M, Kanbar A, Comperat E, Dupont-Athenor A, Alechinsky L, Mouton M, et al. Renal Oncocytoma: An Algorithm for Diagnosis and Management. Urology. 2020;143:173–80. doi: https://doi.org/10.1016/j.urology.2020.05.047
Nicolau C, Antunes N, Paño B, Sebastia C. Imaging Characterization of Renal Masses. Medicina. 2021;57(1):51. doi: https://doi.org/10.3390/medicina57010051
Valdés Olmos RA, de Geus-Oei L-F, Ticheler CHJM, Bloem JL. From Incidentaloma to Oncocytoma: A Role for Hybrid Molecular Imaging in Characterising Renal Masses? Eur Urol. 2016;69(3):417–8. doi: https://doi.org/10.1016/j.eururo.2015.09.040
Giambelluca D, Pellegrino S, Midiri M, Salvaggio G. The “central stellate scar” sign in renal oncocytoma. Abdom Radiol. 2019;44(5):1942–3. doi: https://doi.org/10.1007/s00261-019-01899-3
Mileto A, Potretzke TA. Standardized Evaluation of Small Renal Masses Using the MRI Clear Cell Likelihood Score. Radiology. 2022;303(3):600–2. doi: https://doi.org/10.1148/radiol.220054
Moch H, Ohashi R. Chromophobe renal cell carcinoma: current and controversial issues. Pathology. 2021;53(1):101–8. doi: https://doi.org/10.1016/j.pathol.2020.09.015
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Revista Mexicana de Urología
This work is licensed under a Creative Commons Attribution 4.0 International License.